Prevention of spontaneous autoimmune diabetes in diabetes-prone BB rats by prophylactic treatment with antirat interferon-γ antibody

Endocrinology

Volumn 138, Issue 1, 1997, Pages 281-288

  Nicoletti, Ferdinando ^a,b,d   Zaccone, Paola ^b   Di Marco, Roberto ^b   Lunetta, Michele ^b   Magro, Gaetano ^b   Grasso, Sebastiano ^b   Meroni, Pierluigi ^a   Garotta, Gianni ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c GLAXOSMITHKLINE   (United States)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG RESEARCH; DRUG SCREENING; IMMUNOHISTOLOGY; IMMUNOPHARMACOLOGY; IMMUNOTHERAPY; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031023298     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.1.4846     Document Type: Article

References (46)

1. Mordes JP, Desemone J, Rossini AA 1987 The BB rat. Diabetes Metab Rev 3:725-750
2. Castano L, Eisenbarth GS 1990 Type 1 diabetes: a chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 8:647-663
3. Bach JF 1994 Insulin-dependent diabetes mellitus as an autoimune disease. Endocr Rev 15:516-542
4. Bendtzen K 1989 Immune hormones (cytokines) pathogenic role in autoimmune rheumatic diseases and endocrine diseases. Autoimmunity 2:177-189
5. Mandrup-Poulsen T, Helqvist S, Wogensen LD, Molvig J, Pociot F, Johannesen J, Nerup J 1990 Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells. Curr Top Microbiol Immunol 164:169-193
6. Rabinovitch A 1992 Roles of cytokines in IDDM pathogenesis and islet beta cell destruction. Diabetes Rev 1:215-240
7. Tovo PA, Cerruti F, Palomba E, Salomone C, Pugliese A 1984 Evidence of circulating interferon-γ in newly diagnosed diabetic children. Acta Paediatr Scand 73:785-788
8. Nicoletti F, Meroni PL, Barcellini W, Grasso S, Borghi MO, Lunetta M, Di Marco R, Stefani S, Mughini L 1991 FK506 prevents diabetes in BB/Wor rats. Int J Immunopharmacol 13:1027-1030
9. Foulis AK, McGill M, Farquharson MA 1991 Insulitis in typo 1 (insulin-dependent) diabetes mellitus in man: macrophages, lymphocytes and interferon-γ containing cells. J Pathol 164:97-103
10. Zipris D, Greiner DL, Malkani S, Whalen B, Mordes JP, Rossini AA 1996 Cytokine gene expression in islets and thyroids of BB rats. IFN-γ and IL-12 p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. J Immunol 156:1315-1321
11. Rabinovitch A, Suarez-Pinzon W, El-Sheikh A, Sorensen O, Power RF 1996 Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats. Expression of Th1 cytokines correlate with β-cell destructive insulitis and IDDM. Diabetes 45:749-754
12. Haskins K, Portas M, Bergman B, Lafferty K, Bradley B 1989 Pancreatic islet-specific T cell clones from nonobese diabetic mice. Proc Natl Acad Sci USA 86:8000-8009
13. Anderson JT, Cornelius JG, Jarpe AJ, Winter WE, Peck AB 1993 Insulin-dependent diabetes mellitus in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a Th2 and not a Th1-mediated event. Autoimmunity 15:113-122
14. Rohte H, Faust A, Schade U, Kleeman R, Bosse G, Hibino T, Martin S, Kolb H 1994 Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-γ, but not of interleukin-4. Diabetologia 37:1154-1158
15. Katz JD, Benoist C, Mathis D 1995 T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188
16. Sarvetnick N, Liggit D, Pitts SL, Hansen SE, Stewart TA 1988 Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of MHC class II antigens and interferon-γ. Cell 52:773-782
17. Sarvetnick N, Shizuru J, Liggit D, Martin L, McIntyre B, Gregory A, Parslow W, Stweart T 1990 Loss of pancreatic islet tolerance induced by beta cell expression of interferon-γ. Nature 346:844-847
18. Campbell IL, Kay TWH, Oxbrow L, Harrison LC 1991 Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Whei mice. J Clin Invest 87:739-742
19. Debray-Sachs M, Carnaud C, Boitard C, Cohen H, Gresser I Bedossa P, Bach JF 1991 Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ. J Autoimmun 4:237-248
20. Pennline KJ, Roque-Gaffney E, Monahan M 1994 Recombinant human IL-10 prevents the onset of diabetes in nonobese diabetic mouse. Clin Immunol Immunopathol 71:169-175
21. Nicoletti F, Zaccone P, Di Marco R, Di Mauro M, Magro G, Grasso S, Mughini L, Meroni PL, Garotta G, The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in NOD mouse. Endocrinology, in press
22. Cockfield SM, Ramassar V, Urmson J, Halloran PF 1989 Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-γ. J Immunol 142:1120-1128
23. Kurschner C, Ozmen L, Garotta G, Dembic Z 1992 IFN-γ receptor-Ig fusion proteins. Half-life, immunogenicity and in vivo activity. J Immunol 149:4096-4100
24. Nicoletti F, Meroni PL, Landolfo S, Gariglio M, Guzzardi S, Barcellini W, Lunetta M, Mughini L, Zanussi C 1990 Prevention of diabetes in BB/Wor rats with monoclonal antibodies against rat γ-interferon. Lancet 336:319
25. Jacob CO, Holoshitz J, Van Der Meide P, Strobber S, McDevitt HO 1988 Heterogeneous effects of IFN-γ in adjuvant arthritis. J Immunol 142:1500-15115
26. Boissier MC, Chiocchia G, Hajnal J, Garotta G, Nicoletti F, Fournier C 1995 Biphasic effect of interferon-γ in murine collagen-induced arthritis. Eur J Immunol 25:1184-1190
27. Strigard K, Holmdahl R, van der Meide P, Klareskog L, Olsson T 1989 In vivo treatment of rats with monoclonal antibodies against γ interferon: effects on experimental allergic neuritis. Acta Neurol Scand 80:201-207
28. Gray PW, Goeddel DV 1983 Cloning and expression of murine immune interferon cDNA. Proc Natl Acacl Sci USA 80:5842-5851
29. Nicoletti F, Meroni PL, Di Marco R, Grasso S, Barcellini W, Borghi MO, Lunetta M, Mughini L, Menta R, Schorlemmer HU, Zanussi C 1992 The effects of Deoxyspergualin on the development of diabetes in diabetes-prone BB rats. Scand J Immunol 36:415-420
30. Finck BK, Chan B, Wofsy D 1994 Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest 94:585-591
31. Hosszufalusi N, Chan E, Granger G, Charles MA 1992 Quantitative analyses comparing all major spleen cell phenotypes in BB and normal rats: autoimmune imbalance and double negative T cells associated with resistant, prone and diabetic animals. J Autoimmun 5:305-318
32. Klein B, Brailly H 1995 Cytokine-binding proteins: stimulating antagonists. Immunol Today 16:216-220
33. Landolfo S, Garotta G 1991 IFN-γ. An immunomodulatory and proinflammatory lymphokine. J Immunol Res 9:81-94
34. Kolb H, Kolb-Bachofen V, Roep BO 1995 Autoimmune vs. inflammatory type 1 diabetes: a controversy? Immunol Today 16:170-172
35. Hultgren B, Huang X, Dybdal N, Stewart T 1996 Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45:812-817
36. Ewel CH, Sobel DO, Zeligs BJ, Bellanti JA 1992 Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes 41:1016-1021
37. Dayer-Metroz MD, Duhamel D, Rufer N, Izui S, Carmichaels D, Wollheim CB, Thompson RC, Dayer JM 1992 IL-1 receptor antagonist delays spontaneous autoimmune diabetes in BB rats. Eur J Clin Invest 22:A50 (Abstract)
38. Whalen BJ, Rossini AA, Mordes JP, Greiner DL 1995 DR-BB rat thymus contains thymocyte populations predisposed to autoreactivity. Diabetes 44:963-967
39. Suffredini AF, Reda D, Banks SM, Tropea M, Agosti JM, Miller R 1995 Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration. J Immunol 155:5038-5045
40. Schroeder TJ, First MR, Mansour ME, Hurtubise PE, Hariharan S, Ryckkman FC, Munda R, Melvin DF, Penn I, Ballistreri WF, Wesley AJ 1990 Antimurine antibody formation following OKT3 therapy. Transplantation 49:48-51
41. Allegre M-L, Sattar HA, Herold KC, Smith J, Tepper MA, Bluestone JA 1994 Prevention of the humoral response induced by an anti-CD3 monoclonal antibody by deoxyspergualin in a murine model. Transplantation 57:1786-1794
42. Garotta G, Ozmen L, Fountoulakis M, Dembic Z, Van Loon APGM, Stueber D 1990 Human IFN-γ receptor: mapping of epitopes recognized by neutralizing antibodies using native and recombinant proteins. J Biol Chem 265:6908-6915
43. Fountoulakis M, Schlager EJ, Gentz R, Juranville JF, Manneberg M, Ozmen L, Garotta G 1991 Purification and biochemical characterization of a soluble mouse interferon-γ receptor produced in insect cells. Eur J Biochem 198:441-448
44. Gentz R, Hoyes A, Dasulin K, Boy MC, Malucelli M, Fountoulakis M, Lahn HW, Ozmen L, Garotta G 1992 Expression of soluble IFN-γ receptor by recombinant baculovirus. Eur J Biochem 240:545-554
45. Ozmen L, Gribaudo G, Fountoulakis M, Gentz R, Landolfo S, Garotta G 1993 Mouse soluble IFN-γ receptor as IFN-γ inhibitor. Distribution, antigenicity and activity after injection in mice. J Immunol 150:2698-2705
46. Ozmen L, Roman D, Fountoulakis M, Schmid G, Ryffel B, Garotta G 1995 Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-γ receptor inhibits the onset of glomerulonephritis. Eur J Immunol 25:6-12